Stalenhoef A - Search Results

1

Compromised LCAT function is associated with increased atherosclerosis.

Hovingh GK, Hutten BA, Holleboom AG, Petersen W, Rol P, Stalenhoef A, Zwinderman AH, de Groot E, Kastelein JJ, Kuivenhoven JA. Hovingh GK, et al. Among authors: stalenhoef a. Circulation. 2005 Aug 9;112(6):879-84. doi: 10.1161/CIRCULATIONAHA.105.540427. Epub 2005 Aug 1. Circulation. 2005. PMID: 16061733

2

Carotid atherosclerosis progression in familial hypercholesterolemia patients: a pooled analysis of the ASAP, ENHANCE, RADIANCE 1, and CAPTIVATE studies.

Vergeer M, Zhou R, Bots ML, Duivenvoorden R, Koglin J, Akdim F, Mitchel YB, Huijgen R, Sapre A, de Groot E, Sijbrands EJ, Pasternak RC, Gagné C, Marais AD, Ballantyne CM, Isaacsohn JL, Stalenhoef AF, Kastelein JJ. Vergeer M, et al. Among authors: stalenhoef af. Circ Cardiovasc Imaging. 2010 Jul;3(4):398-404. doi: 10.1161/CIRCIMAGING.109.909655. Epub 2010 May 21. Circ Cardiovasc Imaging. 2010. PMID: 20494942

3

Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study.

de Grooth GJ, Kuivenhoven JA, Stalenhoef AF, de Graaf J, Zwinderman AH, Posma JL, van Tol A, Kastelein JJ. de Grooth GJ, et al. Among authors: stalenhoef af. Circulation. 2002 May 7;105(18):2159-65. doi: 10.1161/01.cir.0000015857.31889.7b. Circulation. 2002. PMID: 11994249 Clinical Trial.

4

The significance of femoral intima-media thickness and plaque scoring in the Atorvastatin versus Simvastatin on Atherosclerosis Progression (ASAP) study.

van Wissen S, Smilde TJ, de Groot E, Hutten BA, Kastelein JJ, Stalenhoef AF. van Wissen S, et al. Among authors: stalenhoef af. Eur J Cardiovasc Prev Rehabil. 2003 Dec;10(6):451-5. doi: 10.1097/01.hjr.0000103277.02552.1e. Eur J Cardiovasc Prev Rehabil. 2003. PMID: 14671468 Clinical Trial.

5

A review of CETP and its relation to atherosclerosis.

de Grooth GJ, Klerkx AH, Stroes ES, Stalenhoef AF, Kastelein JJ, Kuivenhoven JA. de Grooth GJ, et al. J Lipid Res. 2004 Nov;45(11):1967-74. doi: 10.1194/jlr.R400007-JLR200. Epub 2004 Sep 1. J Lipid Res. 2004. PMID: 15342674 Free article. Review.

6

Cholesteryl ester transfer protein inhibitor torcetrapib and off-target toxicity: a pooled analysis of the rating atherosclerotic disease change by imaging with a new CETP inhibitor (RADIANCE) trials.

Vergeer M, Bots ML, van Leuven SI, Basart DC, Sijbrands EJ, Evans GW, Grobbee DE, Visseren FL, Stalenhoef AF, Stroes ES, Kastelein JJ. Vergeer M, et al. Circulation. 2008 Dec 9;118(24):2515-22. doi: 10.1161/CIRCULATIONAHA.108.772665. Epub 2008 Nov 24. Circulation. 2008. PMID: 19029469 Clinical Trial.

7

Pregnancy in women suffering from familial hypercholesterolemia: a harmful period for both mother and newborn?

Avis HJ, Hutten BA, Twickler MT, Kastelein JJ, van der Post JA, Stalenhoef AF, Vissers MN. Avis HJ, et al. Among authors: stalenhoef af. Curr Opin Lipidol. 2009 Dec;20(6):484-90. doi: 10.1097/MOL.0b013e3283319127. Curr Opin Lipidol. 2009. PMID: 19741526 Review.

8

Differential hs-CRP reduction in patients with familial hypercholesterolemia treated with aggressive or conventional statin therapy.

van Wissen S, Trip MD, Smilde TJ, de Graaf J, Stalenhoef AF, Kastelein JJ. van Wissen S, et al. Atherosclerosis. 2002 Dec;165(2):361-6. doi: 10.1016/s0021-9150(02)00280-0. Atherosclerosis. 2002. PMID: 12417288 Clinical Trial.

9

Effect of atorvastatin (80 mg) and simvastatin (40 mg) on plasma fibrinogen levels and on carotid intima media thickness in patients with familial hypercholesterolemia.

Trip MD, van Wissen S, Smilde TJ, Hutten BA, Stalenhoef AF, Kastelein JJ. Trip MD, et al. Among authors: stalenhoef af. Am J Cardiol. 2003 Mar 1;91(5):604-6. doi: 10.1016/s0002-9149(02)03318-0. Am J Cardiol. 2003. PMID: 12615272 Clinical Trial. No abstract available.

10

The relationship between cholesteryl ester transfer protein levels and risk factor profile in patients with familial hypercholesterolemia.

de Grooth GJ, Smilde TJ, Van Wissen S, Klerkx AH, Zwinderman AH, Fruchart JC, Kastelein JJ, Stalenhoef AF, Kuivenhoven JA. de Grooth GJ, et al. Atherosclerosis. 2004 Apr;173(2):261-7. doi: 10.1016/j.atherosclerosis.2003.11.020. Atherosclerosis. 2004. PMID: 15064100 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

352 results

Search Page